Abstract 4364350: Impact of Prior Myocardial Infarction on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention

M Michaella Alexandrou (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) D Dimitrios Strepkos (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) P Pedro Carvalho (Ernst Strüngmann Institute) D Deniz Mutlu (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) O Ozgur Ser (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) E Eleni Kladou (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) B Babar Basir (Henry Ford Cardiovascular Division, Detroit, Michigan, United States) K Khaldoon Alaswad (Henry Ford Cardiovascular Division, Detroit, Michigan, United States) O Oleg Krestyaninov (NMRC E.N. Meshalkin, Novosibirsk, Russian Federation) J Jaikirshan Khatri (Weill Cornell Medical Center, New York, New York, United States) L Laura Young (Cleveland Clinic Foundation, Cleveland, Ohio, United States) O OMER GOKTEKIN (MEMORIAL HOSPITAL, ISTANBUL, Turkey) P Paul Poommipanit (University Hospitals, Parma, Ohio, United States) F Farouc Jaffer (MASSACHUSETTS GENERAL HOSPITAL, Boston, Massachusetts, United States) S Sevket Gorgulu (Biruni University Medical School, Istanbul, Turkey) A Ahmed El Guindy (Aswan Heart Centre, Aswan, Egypt) N Nidal Abi Rafeh, MD, FACC (Northoaks Healthsystem, Covington, Louisiana, United States) D Diya Arun (Promed Hospital, Chennai, India) A Arun Kalyanasundaram (Promed Hospital, Chennai, India) D Dmitrii Khelimskii (NMRC E.N. Meshalkin, Novosibirsk, Russian Federation) B Bavana Rangan (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) O Olga Mastrodemos (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) S Sandeep Jalli (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) K Konstantinos Voudris (Minneapolis Heart Institute, Minneapolis, Minnesota, United States) Y Yader Sandoval (Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital and Center for Coronary Artery Disease, Minneapolis Heart Institute Foundation Minneapolis) M M Nicholas Burke (Minneapolis Heart Institute, Mpls, Minnesota, United States) L Lorenzo Azzalini (Minneapolis Heart Institute Foundat, Minneapolis, Minnesota, United States) E Emmanouil Brilakis (Minneapolis Heart Institute, Edina, Minnesota, United States)

Abstract

Background: The impact of prior myocardial infarction (MI) on the outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains understudied. Methods: We compared the characteristics and outcomes of 15,461 patients with versus without history of prior MI who underwent 15,478 CTO PCIs between 2012-2025 at 58 US and non-US centers (PROGRESS-CTO registry). Results: 43.2% (n=6,677) of the patients had history of prior MI. Prior MI patients were younger and more likely to be men, to have hypertension, lower left ventricular ejection fraction, cerebrovascular and peripheral arterial disease. Patients with prior MI that did not have prior PCI (22.8%), were more likely to have a myocardial viability test performed (32.6% vs 27.3%, p<0.001). The lesions of patients with prior MI had higher J-CTO (2.41 vs 2.34, p<0.001) and PROGRESS-CTO (1.25 vs 1.16, p<0.001) scores, higher lesion diameter, longer lesion length, were more likely to have proximal cap ambiguity (35.5% vs 33.8%, p=0.035), side branch at the proximal cap (58.3% vs 56.2%, p=0.014) and moderate/severe tortuosity (28.8% vs 24.6%, p<0.001). They had higher use of the retrograde wiring technique (33.3% vs 29.4%, p<0.001), longer procedural and fluoroscopy times and higher contrast and radiation use. Prior MI cases had lower technical (85.6% vs 88.8%, p<0.001) and procedural (84.3% vs 87.7%, p<0.001) success, but similar major adverse cardiac events (MACE) (2.1% vs 1.7%, p=0.113). They were more likely to experience in-hospital acute MI (0.6% vs 0.4%, p=0.046), coronary perforation (5.0% vs 4.3%, p=0.039) and have elective peripheral ventricular assist device use (2.3% vs 1.7%, p=0.006). In multivariable analysis, prior MI was independently associated with lower technical success (odds ratio (OR) 0.79, 95%CI 0.70-0.89). For 3,546 prior MI cases (53.1%) data regarding the location of the prior MI was available. Most (53.6%) had prior MI in the area that was perfused by the totally occluded vessel. These cases were more likely to have a prior myocardial viability test (29.6% vs 19.7%, p<0.001), had lower technical (83.9% vs 86.3%, p=0.052), with the association persisting in the multivariable analysis (OR 0.62, 95%CI 0.47-0.83), but similar procedural success (82.9% vs 85.2%, p=0.063) and MACE (1.7% vs 1.5%, p=0.712). Conclusions: Patients with prior MI undergoing CTO PCI have more comorbidities and higher lesion complexity, achieve lower technical success but have similar MACE.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (28)

M

Michaella Alexandrou

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

D

Dimitrios Strepkos

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

P

Pedro Carvalho

Ernst Strüngmann Institute

D

Deniz Mutlu

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

O

Ozgur Ser

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

E

Eleni Kladou

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

B

Babar Basir

Henry Ford Cardiovascular Division, Detroit, Michigan, United States

K

Khaldoon Alaswad

Henry Ford Cardiovascular Division, Detroit, Michigan, United States

O

Oleg Krestyaninov

NMRC E.N. Meshalkin, Novosibirsk, Russian Federation

J

Jaikirshan Khatri

Weill Cornell Medical Center, New York, New York, United States

L

Laura Young

Cleveland Clinic Foundation, Cleveland, Ohio, United States

O

OMER GOKTEKIN

MEMORIAL HOSPITAL, ISTANBUL, Turkey

P

Paul Poommipanit

University Hospitals, Parma, Ohio, United States

F

Farouc Jaffer

MASSACHUSETTS GENERAL HOSPITAL, Boston, Massachusetts, United States

S

Sevket Gorgulu

Biruni University Medical School, Istanbul, Turkey

A

Ahmed El Guindy

Aswan Heart Centre, Aswan, Egypt

N

Nidal Abi Rafeh, MD, FACC

Northoaks Healthsystem, Covington, Louisiana, United States

D

Diya Arun

Promed Hospital, Chennai, India

A

Arun Kalyanasundaram

Promed Hospital, Chennai, India

D

Dmitrii Khelimskii

NMRC E.N. Meshalkin, Novosibirsk, Russian Federation

B

Bavana Rangan

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

O

Olga Mastrodemos

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

S

Sandeep Jalli

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

K

Konstantinos Voudris

Minneapolis Heart Institute, Minneapolis, Minnesota, United States

Y

Yader Sandoval

Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital and Center for Coronary Artery Disease, Minneapolis Heart Institute Foundation Minneapolis

M

M Nicholas Burke

Minneapolis Heart Institute, Mpls, Minnesota, United States

L

Lorenzo Azzalini

Minneapolis Heart Institute Foundat, Minneapolis, Minnesota, United States

E

Emmanouil Brilakis

Minneapolis Heart Institute, Edina, Minnesota, United States